Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artificial Human Skin Created Using Tissue Engineering

By LabMedica International staff writers
Posted on 03 May 2010
A new study describes the development of artificial human skin with biomechanical properties, based on an agarose-fibrin biomaterial.

Researchers at the University of Granada (UGR; Spain) first obtained human skin samples from biopsies of patients who underwent plastic surgery at the University Hospital Virgen de las Nieves (Granada, Spain). More...
To create the artificial human skin, tranexamic acid (to prevent fibrinolysis), calcium chloride (to precipitate fibrin coagulation), and 0.1% agarose was added to human fibrin from plasma of healthy donors. The artificial-skin substitutes were then grafted on the back of the nude mice, with the purpose of observing its optimal development, maturation, and functionality in vivo. To do so, the researchers analyzed the samples by transmission and scanning light, electron microscopy, and inmunofluorescence to evaluate factors such as cell proliferation, the presence of differentiating morphological markers, the expression of cytokeratin, involucrine, filaggrin, and angiogenesis of the artificial skin into the recipient organism.

The researchers found that the artificial human skin created in the laboratory showed adequate biocompatibility rates with the recipient, and no rejection, dehiscence, or infection was registered. Additionally, the skin of all animals used in the study started to show granulation after six days from implantation. Within the following twenty days, cicatrization was complete. Details on the research were released by the department of histology at UGR on April 20, 2010.

"These biomaterials added resistance, firmness, and elasticity to the skin. Definitively, we have created a more stable skin with similar functionality to normal human skin,” said lead author José María Jiménez Rodríguez, of the tissular engineering research group at UGR. ”This pioneering finding will allow the clinical use of human skin and its use in many laboratory tests on biological tissues. Further, this finding could be useful in developing new treatment approaches for dermatological pathologies.”

Related Links:
University of Granada
University Hospital Virgen de las Nieves


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.